BIOGEN INC. (BIIB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 5B 10B 15B FY07: 3.2B FY08: 4.1B FY09: 4.4B FY10: 4.7B FY11: 5B FY12: 5.5B FY13: 6.9B FY14: 9.7B FY15: 10.8B FY16: 11.4B FY17: 12.3B FY18: 13.5B FY19: 14.4B FY20: 13.4B FY21: 11B FY22: 10.2B FY23: 9.8B FY24: 9.7B FY25: 9.9B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 5B 10B 15B FY09: 4B FY10: 4.3B FY11: 4.6B FY12: 5B FY13: 6.1B FY14: 8.5B FY15: 9.5B FY16: 10B FY17: 10.6B FY18: 11.6B FY19: 12.4B FY20: 11.6B FY10 FY12 FY14 FY16 FY18 FY20

Operating Income Annual

0 2.5B 5B 7.5B FY07: 779.8M FY08: 1.2B FY09: 1.3B FY10: 1.2B FY11: 1.7B FY12: 1.9B FY13: 2.5B FY14: 4B FY15: 4.9B FY16: 5.2B FY17: 5.3B FY18: 5.9B FY19: 7B FY20: 4.6B FY21: 2.8B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21

Net Income Annual

0 2.5B 5B 7.5B FY07: 638.2M FY08: 783.2M FY09: 970.1M FY10: 1B FY11: 1.2B FY12: 1.4B FY13: 1.9B FY14: 2.9B FY15: 3.5B FY16: 3.7B FY17: 2.5B FY18: 4.4B FY19: 5.9B FY20: 4B FY21: 1.6B FY22: 3B FY23: 1.2B FY24: 1.6B FY25: 1.3B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 900M 1.8B 2.7B FY07: 335.2M FY08: 402M FY09: 382.1M FY10: 400.3M FY11: 466.8M FY12: 545.5M FY16: 1.5B FY17: 1.6B FY18: 1.8B FY19: 2B FY20: 1.8B FY21: 2.1B FY22: 2.3B FY23: 2.5B FY24: 2.3B FY25: 2.4B FY08 FY10 FY12 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 2.5B 5B 7.5B FY07: 1B FY08: 1.6B FY09: 1.1B FY10: 1.6B FY11: 1.7B FY12: 1.9B FY13: 2.3B FY14: 2.9B FY15: 3.9B FY16: 4.6B FY17: 4.6B FY18: 6.2B FY19: 7.1B FY20: 4.2B FY21: 3.6B FY22: 1.4B FY23: 1.5B FY24: 2.9B FY25: 2.2B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 2.5B 5B 7.5B FY07: 734.6M FY08: 1.3B FY09: 909.3M FY10: 1.5B FY11: 1.5B FY12: 1.6B FY13: 2.1B FY14: 2.7B FY15: 3.3B FY16: 4B FY17: 3.7B FY18: 5.4B FY19: 6.6B FY20: 3.8B FY21: 3.4B FY22: 1.1B FY23: 1.3B FY24: 2.7B FY25: 2.1B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 150M 300M 450M FY07: 320.2M FY08: 295M FY09: 289.5M FY10: 254.9M FY11: 245M FY12: 239.7M FY13: 238.3M FY14: 237.2M FY15: 231.2M FY16: 218.8M FY17: 213M FY18: 205.3M FY19: 187.4M FY20: 161.3M FY21: 149.6M FY22: 146M FY23: 145.6M FY24: 145.9M FY25: 147.1M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 15.00 30.00 45.00 Q4 '08: 2.65 Q1 '09: 2.94 Q2 '09: 2.73 Q3 '09: 2.98 Q4 '09: 3.34 Q1 '10: 3.30 Q2 '10: 3.93 Q3 '10: 4.03 Q4 '10: 3.96 Q1 '11: 4.36 Q2 '11: 4.42 Q3 '11: 4.80 Q4 '11: 5.03 Q1 '12: 5.08 Q2 '12: 5.51 Q3 '12: 5.75 Q4 '12: 5.76 Q1 '13: 6.30 Q2 '13: 6.75 Q3 '13: 7.13 Q4 '13: 7.82 Q1 '14: 8.05 Q2 '14: 9.00 Q3 '14: 10.57 Q4 '14: 12.39 Q1 '15: 13.86 Q2 '15: 14.78 Q3 '15: 15.31 Q4 '15: 15.34 Q1 '16: 16.28 Q2 '16: 17.14 Q3 '16: 17.70 Q4 '16: 16.92 Q1 '17: 15.95 Q2 '17: 15.23 Q3 '17: 16.31 Q4 '17: 11.92 Q1 '18: 14.00 Q2 '18: 14.11 Q3 '18: 15.47 Q4 '18: 21.60 Q1 '19: 23.21 Q2 '19: 26.88 Q3 '19: 28.12 Q4 '19: 31.47 Q1 '20: 32.40 Q2 '20: 34.14 Q3 '20: 30.21 Q4 '20: 24.45 Q1 '21: 19.06 Q2 '21: 12.46 Q3 '21: 10.22 Q4 '21: 10.40 Q1 '22: 9.77 Q2 '22: 14.02 Q3 '22: 19.64 Q4 '22: 20.94 Q1 '23: 21.55 Q2 '23: 18.38 Q3 '23: 10.07 Q4 '23: 7.98 Q1 '24: 8.01 Q2 '24: 7.94 Q3 '24: 11.07 Q4 '24: 11.19 Q1 '25: 10.13 Q2 '25: 10.46 Q3 '25: 10.97 Q4 '25: 8.79 Q1 '26: 9.30 Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q2 '19 Q3 '21 Q4 '23 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.